Hydrogen Bromide → HCID 20329327, compound

HRID 2057919Notes

Reaction equation

HRID 2057919 reaction equation
C(OC([NH:11][CH2:12][C:13]1[N:17]2[C:18]3[CH:33]=[CH:32][C:31]([Cl:34])=[CH:30][C:19]=3[N:20]([C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)[C:21](=[O:23])[CH2:22][C:16]2=[N:15][N:14]=1)=O)C1C=CC=CC=1.Br>C(O)(=O)C>[NH2:11][CH2:12][C:13]1[N:17]2[C:18]3[CH:33]=[CH:32][C:31]([Cl:34])=[CH:30][C:19]=3[N:20]([C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)[C:21](=[O:23])[CH2:22][C:16]2=[N:15][N:14]=1

Participants

4

Reactant 2

HCID 260Hydrogen BromideHCID 20329305HCID 20329305, compound

Product 1

HCID 20329327HCID 20329327, compound

Reagents, catalysts & solvents 1

HCID 176Acetic AcidSolvent

Procedure

4.5 g of 1-[[(benzyloxycarbonyl)amino]-methyl]-8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,5]benzodiazepin-5-one in 60 ml acetic acid saturated with hydrogen bromide is stirred at 20° for 1 hour. The reaction mixture is concentrated to one-half its original volume in vacuo and diluted with ether. The precipitate is filtered off, suspended in methylene chloride and shaken with excess 2 N aqueous sodium bicarbonate. The organic phase is separated, washed with water, dried and evaporated to give the title compound.

Workup

  1. concentrationThe reaction mixture is concentrated to one-half its original volume in vacuo
  2. additiondiluted with ether
  3. filtrationThe precipitate is filtered off
  4. customThe organic phase is separated
  5. washwashed with water
  6. customdried
  7. customevaporated

Sources & evidence

ORD record
ord-1d4ffed1739940bfa3953507ed66eb9d
Source dataset
uspto-grants-1980_07
Patent number
US04213982

Reaction notes

Loading…